Skin cancer remains one of the most common cancers in the United States, making effective sun protection an important component of preventive care. This course reviews sunscreen best practices, common patient questions, and recent updates affecting sunscreen products, including the addition of a new active ingredient to the OTC sunscreen monograph. You will be better prepared to provide evidence-based recommendations on sunscreen selection, sun safety, and skin cancer prevention.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Kendall Guthrie, PharmD, BCACP
Director of Co-Curriculum/Clinical Professor,
UMKC School of Pharmacy

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current recommendations for sunscreen use and sun protection to reduce the risk of skin cancer.
2. Explain pharmacist-relevant considerations for sunscreen selection, including formulation differences, active ingredients, and patient counseling.

Rachel Maynard and Kendall Guthrie have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-289-H01-P
Initial release date: 7/27/2026
Expiration date: 7/27/2029
Additional CPE details can be found here.

Primary open-angle glaucoma is a progressive eye disease that can lead to irreversible vision loss without timely treatment and ongoing monitoring. This course reviews practical approaches to glaucoma management, including treatment goals, common medication options, and factors that influence adherence and long-term disease control. You will be better prepared to support patients receiving glaucoma therapy through medication counseling, adherence support, and reinforcement of appropriate follow-up care.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Stephanie Conway-Allen, PharmD
Associate Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences Worcester/Manchester

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe treatment goals and common management strategies for primary open-angle glaucoma.
2. Explain pharmacist-relevant considerations for counseling and supporting patients receiving glaucoma therapy.

Rachel Maynard and Stephanie Conway-Allen have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-252-H01-P
Initial release date: 7/20/2026
Expiration date: 7/20/2029
Additional CPE details can be found here.

International travel exposes patients to a range of infectious disease risks, making pre-travel planning and vaccination an important part of patient care. This course reviews recent travel health updates, including vaccine recommendations, emerging safety considerations, and prevention strategies for common travel-related illnesses. You will be better prepared to provide evidence-based recommendations, assess patient risk, and counsel travelers on vaccines and preventive measures before international travel.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Lana Saad Sherr, PharmD
Assistant Dean for Professional Affairs,
University of Maryland Eastern Shore

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1.Describe key vaccine recommendations and safety considerations for patients traveling internationally.
2. Describe prevention strategies for common travel-related infectious diseases, including mosquito-borne illnesses.

Rachel Maynard and Lana Sherr have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-251-H01-P
Initial release date: 7/13/2026
Expiration date: 7/13/2027
Additional CPE details can be found here.

Deprescribing is an important component of patient care as medication regimens are reassessed to ensure ongoing appropriateness, safety, and alignment with patient goals. This course reviews key deprescribing principles, including when it may be appropriate to discontinue therapy and important considerations for patient monitoring and follow-up. You will be better prepared to support evidence-based deprescribing decisions and collaborate with patients and providers to optimize medication use.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Kristin S. Meyer, PharmD, BCGP, FASCP
Professor of Pharmacy Practice,
Drake University College of Pharmacy and Health Sciences

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss key principles and clinical considerations for deprescribing.
2. Compare patient-specific factors that influence evidence-based deprescribing decisions, including risks, benefits, and treatment goals.

Rachel Maynard and Kristin Meyer have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-249-H01-P
Initial release date: 7/6/2026
Expiration date: 7/6/2029
Additional CPE details can be found here.

Beta-blockers have long been considered a foundational therapy following myocardial infarction, yet emerging data are challenging their routine use in all patients. This course discusses recent evidence on outcomes associated with beta-blocker therapy after MI, particularly in patients without reduced ejection fraction, and explores the ongoing debate over the benefits, risks, and duration of therapy. You will gain practical insight to support evidence-based decision-making and individualized pharmacotherapy recommendations in post-MI care.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Anna Crider, PharmD, BCCP
Clinical Pharmacy Specialist,
Emory University Hospital

Taylor Merritt, PharmD
PGY2 Internal Medicine Pharmacy Resident, Chief Pharmacy Resident,
Emory University Hospital

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize contemporary evidence regarding beta-blocker therapy after myocardial infarction.
2. Describe clinical considerations that may influence the decision to initiate, continue, or deprescribe beta-blocker therapy following myocardial infarction.

Rachel Maynard, Anna Crider, and Taylor Merritt have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-242-H01-P
Initial release date: 6/29/2026
Expiration date: 6/29/2027
Additional CPE details can be found here.

Social determinants of health impact more patients than we often realize—and many of those barriers show up in the pharmacy every day.

In this episode of Independent Insights, host Britney Woods, Sr. Manager of Community Pharmacy at McKesson Health Mart, sits down with Jennifer Powell, Lead Clinical Pharmacy Technician and Community Health Worker at Gibbs Pharmacy, to discuss how she and her team are actively bridging these gaps to better support their patients.

From helping patients navigate food access and affordability to improving engagement and follow-up, Jenny shares real examples of how this work is helping to improve care and outcomes—and how it can be intentionally integrated into the pharmacy through a Pharmacy Technician Community Health Worker role.

Listen to this insightful conversation to learn how adding a Community Health Worker to your team can help support patient care, engagement, and your pharmacy’s impact in the community.

Host
Britney Woods, PharmD
Sr. Manager, Community Pharmacy
McKesson / Health Mart

Guests
Jennifer Powell, CPhT, CHW, DCCC
Lead Clinical Pharmacy Technician
Gibbs Pharmacy

Resources
Health Mart Pharmacies can access Health Mart University (HMU) for:

• Helpful CE courses and more on Community Health Workers
• Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  

References
National Association of Community Health Workers
Home - NACHW - National Association of Community Health Workers

National Academy for State Health Policies
State Community Health Worker Policies  

CHW Networks & Associations by State
Networks and Training Programs - NACHW - National Association of Community Health Workers

CEimpact Community Health Worker Training
Pharmacy-Based Community Health Worker Training

The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Sexually transmitted infection (STI) management continues to evolve, with new treatment options, prevention strategies, and practice considerations that are important for pharmacists to understand. This course reviews recent updates in STI care, including newly approved oral therapies for gonorrhea and doxycycline post-exposure prophylaxis. You will be better prepared to recognize practice-relevant changes and support evidence-based STI prevention, treatment, and patient counseling.

 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Francisco Franco, PharmD, MS, AAHIVP
Registered Store Manager,
Walgreens

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in STI treatment and prevention that are relevant to pharmacy practice.
2. Compare emerging strategies for managing gonorrhea and STI post-exposure prophylaxis.

Rachel Maynard and Francisco Franco have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-241-H01-P
Initial release date: 6/22/2026
Expiration date: 6/22/2027
Additional CPE details can be found here.

Interest in peptide therapies has grown rapidly, with increasing patient questions driven by social media, wellness trends, and evolving access through compounding and online sources. This course reviews what peptides are, the current state of evidence supporting their use, and key safety and regulatory considerations relevant to patient care. You will be better prepared to apply an evidence-based approach when discussing peptides, including evaluating risks, addressing misconceptions, and guiding patients toward safe and informed decisions.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Nicolette Mathey, PharmD
Founder & CEO

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the role of peptides in human physiology and the current evidence supporting their therapeutic use.
2. Identify safety, regulatory, and patient-specific considerations relevant to the use of peptides in clinical practice.

Rachel Maynard and Nicolette Mathey have no relevant financial relationships to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-240-H01-P
Initial release date: 6/15/2026
Expiration date: 6/15/2027
Additional CPE details can be found here.

Antibiotics are frequently prescribed in dental care, yet evidence suggests they are often unnecessary and can expose patients to significant risks, including Clostridioides difficile infection. This course reviews appropriate antibiotic use in dental settings, including indications, preferred treatment options, and safety concerns associated with specific agents. You will be better prepared to support evidence-based antibiotic use, identify opportunities for intervention, and collaborate with dental colleagues to promote antimicrobial stewardship.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Julie Goldberg, DDS
Senior Dental Risk Specialist
Pharmacists Mutual Insurance Group

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe appropriate indications for antibiotic use in common dental conditions.
2. Compare antibiotic options used in dental care, including safety considerations and risks associated with specific agents.

Rachel Maynard and Julie Goldberg have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-224-H01-P
Initial release date: 6/8/2026
Expiration date: 6/8/2027
Additional CPE details can be found here.

Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Emma Murter, PharmD, MPH
Clinical Pharmacist, Intermountain Health

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Summarize the current evidence on tramadol’s efficacy and safety profile in chronic pain based on placebo-controlled randomized trials.
2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.

Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.

0.05 CEU/0.5 Hr
UAN: 0107-0000-26-223-H01-P
Initial release date: 6/1/2026
Expiration date: 6/1/2027
Additional CPE details can be found here.